Enhancing panic and smoking reduction treatment with d-cycloserine: Study protocol for a randomized controlled trial

Jasper A J Smits1, Brooke Y Kauffman2, Eunjung Lee-Furman1

  • 1Department of Psychology, Institute for Mental Health Research, University of Texas at Austin, Austin, TX, United States.

Summary

This study tests d-cycloserine (DCS) to improve smoking cessation outcomes for panic attack sufferers. DCS may enhance a combined treatment targeting panic and smoking relapse triggers.